Summary

Blood Testing Market Growth & Trends

The global blood testing market size is estimated to reach USD 160.50 billion by 2030, registering a CAGR of 8.83% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributable to various factors including the growing demand for the identification of infectious agents and increased healthcare spending by government and regulatory bodies. Furthermore, the rising prevalence of infectious diseases, such as diabetes, COVID-19, and cardiovascular diseases, is anticipated to drive market growth. For instance, according to the CDC in 2022, approximately 37.3 million people were diagnosed with diabetes in the United States, accounting for 11.3 % of the population.

This increasing prevalence of diabetes creates a significant demand for blood tests, thus contributing to the growth of the market. Furthermore, technological advancement in the products used for blood testing fuels the growth of the market. The availability of portable glucose meters that enable patients to perform routine checkups conveniently and anywhere has contributed to an expansion of the market. In addition, the monitoring of diabetes is crucial prior to any surgical intervention for patients with diabetes, which further drives the demand for these products. The introduction of new products is anticipated to fuel market growth over the projection period.

For instance, in May 2022, Labcorp introduced an at-home collection kit with Labcorp OnDemand, which allows individuals to measure their hemoglobin A1c (HbA1c) levels from a small blood sample to monitor their sugar levels. Key organizations, such as the American Red Cross, the New York Blood Center, America's Blood Centers, Armed Services Blood Program, AABB, and Blood Centers of America, play a crucial role in providing information on plasma collection and delivery. The rise in blood donations is expected to further drive the demand for testing products used in pre-transplant and post-transplant procedures, thereby boosting market growth.

Blood Testing Market Report Highlights

• The glucose testing segment held the largest revenue share in 2024. The segment growth is supported by the increasing prevalence of both type I and type II diabetes, along with the growing number of cases related to hereditary diabetes

• Continuous advancements in technology have led to the development of innovative blood testing methods and devices. These advancements, such as point-of-care testing, wearable devices, and improved laboratory testing techniques, drive market growth.

• North America held the largest revenue share in 2024 and is expected to maintain its position throughout the forecast period; however, Asia Pacific is expected to grow at a significant rate from 2025 to 2030

• Key players operating are focusing on product launches and geographical expansion to maintain their presence. For instance, in March 2023, Apple made notable progress in the development of non-invasive blood glucose monitoring technology, enabling individuals with diabetes and other conditions to measure their blood glucose levels without the need for skin pricks or traditional blood testing methods

• In June 2022, Apollo Cancer Centers, in collaboration with Datar Cancer Genetics, introduced a blood test capable of detecting early-stage breast cancers in asymptomatic individuals.

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Information Analysis
1.2.2. Market Formulation & Data Visualization
1.2.3. Data Validation & Publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objective
1.9.1. Objective 1
1.9.2. Objective2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing prevalence of target disease
3.2.1.2. Growing demand for point-of-care tests
3.2.1.3. Implementation of favorable government initiatives & external funding for R&D activities
3.2.1.4. Introduction of CLIA waived tests
3.2.1.5. Rising demand for early disease detection
3.2.2. Market Restraint Analysis
3.2.2.1. Stringent regulatory and reimbursement policies
3.2.2.2. Limitations associated with blood testing
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
Chapter 4. Collection Site Business Analysis
4.1. Blood Testing Market: Collection Site Dashboard
4.2. Blood Testing Market: Collection Site Movement Analysis
4.3. Blood Testing Market by Collection Site, Revenue
4.4. Glucose Testing
4.4.1. Glucose Testing Market, 2018 - 2030 (USD Million)
4.5. A1C Testing
4.5.1. A1C Testing Market, 2018 - 2030 (USD Million)
4.6. Direct LDL Testing
4.6.1. Direct LDL Testing Market, 2018 - 2030 (USD Million)
4.7. Lipid Panel Testing
4.7.1. Lipid Panel Testing Market, 2018 - 2030 (USD Million)
4.8. Prostate Specific Antigen Testing
4.8.1. Prostate Specific Antigen Testing Market, 2018 - 2030 (USD Million)
4.9. COVID-19 Testing
4.9.1. COVID-19 Testing Market, 2018 - 2030 (USD Million)
4.10. BUN Testing
4.10.1. BUN Testing Market, 2018 - 2030 (USD Million)
4.11. Vitamin D Testing
4.11.1. Vitamin D Testing Market, 2018 - 2030 (USD Million)
4.12. Thyroid Stimulating Hormone (TSH) Testing
4.12.1. Thyroid Stimulating Hormone (TSH) Testing Market, 2018 - 2030 (USD Million)
4.13. Serum Nicotine/Cotinine Testing
4.13.1. Serum Nicotine/Cotinine Testing Market, 2018 - 2030 (USD Million)
4.14. High Sensitivity CRP Testing
4.14.1. High Sensitivity CRP Testing Market, 2018 - 2030 (USD Million)
4.15. Testosterone Testing
4.15.1. Testosterone Testing Market, 2018 - 2030 (USD Million)
4.16. ALT Testing
4.16.1. ALT Testing Market, 2018 - 2030 (USD Million)
4.17. Cortisol Testing
4.17.1. Cortisol Testing Market, 2018 - 2030 (USD Million)
4.18. Creatinine Testing
4.18.1. Creatinine Testing Market, 2018 - 2030 (USD Million)
4.19. AST Testing
4.19.1. AST Testing Market, 2018 - 2030 (USD Million)
4.20. Other Blood Tests
4.20.1. Other Blood Tests Market, 2018 - 2030 (USD Million)
Chapter 5. Regional Business Analysis
5.1. Blood Testing Market Share By Region, 2024 & 2030
5.2. North America
5.2.1. North America Blood Testing Market, 2018 - 2030 (USD Million)
5.2.2. U.S.
5.2.2.1. Key Country Dynamics
5.2.2.2. Competitive Scenario
5.2.2.3. Regulatory Framework
5.2.2.4. U.S. Blood Testing Market, 2018 - 2030 (USD Million)
5.2.3. Canada
5.2.3.1. Key Country Dynamics
5.2.3.2. Competitive Scenario
5.2.3.3. Regulatory Framework
5.2.3.4. Canada Blood Testing Market, 2018 - 2030 (USD Million)
5.2.4. Mexico
5.2.4.1. Key Country Dynamics
5.2.4.2. Competitive Scenario
5.2.4.3. Regulatory Framework
5.2.4.4. Mexico Blood Testing Market, 2018 - 2030 (USD Million)
5.3. Europe
5.3.1. Europe Blood Testing Market, 2018 - 2030 (USD Million)
5.3.2. UK
5.3.2.1. Key Country Dynamics
5.3.2.2. Competitive Scenario
5.3.2.3. Regulatory Framework
5.3.2.4. UK Blood Testing Market, 2018 - 2030 (USD Million)
5.3.3. Germany
5.3.3.1. Key Country Dynamics
5.3.3.2. Competitive Scenario
5.3.3.3. Regulatory Framework
5.3.3.4. Germany Blood Testing Market, 2018 - 2030 (USD Million)
5.3.4. France
5.3.4.1. Key Country Dynamics
5.3.4.2. Competitive Scenario
5.3.4.3. Regulatory Framework
5.3.4.4. France Blood Testing Market, 2018 - 2030 (USD Million)
5.3.5. Italy
5.3.5.1. Key Country Dynamics
5.3.5.2. Competitive Scenario
5.3.5.3. Regulatory Framework
5.3.5.4. Italy Blood Testing Market, 2018 - 2030 (USD Million)
5.3.6. Spain
5.3.6.1. Key Country Dynamics
5.3.6.2. Competitive Scenario
5.3.6.3. Regulatory Framework
5.3.6.4. Spain Blood Testing Market, 2018 - 2030 (USD Million)
5.3.7. Sweden
5.3.7.1. Key Country Dynamics
5.3.7.2. Competitive Scenario
5.3.7.3. Regulatory Framework
5.3.7.4. Sweden Blood Testing Market, 2018 - 2030 (USD Million)
5.3.8. Norway
5.3.8.1. Key Country Dynamics
5.3.8.2. Competitive Scenario
5.3.8.3. Regulatory Framework
5.3.8.4. Norway Blood Testing Market, 2018 - 2030 (USD Million)
5.3.9. Denmark
5.3.9.1. Key Country Dynamics
5.3.9.2. Competitive Scenario
5.3.9.3. Regulatory Framework
5.3.9.4. Denmark Blood Testing Market, 2018 - 2030 (USD Million)
5.3.10. Russia
5.3.10.1. Key Country Dynamics
5.3.10.2. Competitive Scenario
5.3.10.3. Regulatory Framework
5.3.10.4. Russia Blood Testing Market, 2018 - 2030 (USD Million)
5.4. Asia Pacific
5.4.1. Asia Pacific Blood Testing Market, 2018 - 2030 (USD Million)
5.4.2. China
5.4.2.1. Key Country Dynamics
5.4.2.2. Competitive Scenario
5.4.2.3. Regulatory Framework
5.4.2.4. China Blood Testing Market, 2018 - 2030 (USD Million)
5.4.3. India
5.4.3.1. Key Country Dynamics
5.4.3.2. Competitive Scenario
5.4.3.3. Regulatory Framework
5.4.3.4. India Blood Testing Market, 2018 - 2030 (USD Million)
5.4.4. Japan
5.4.4.1. Key Country Dynamics
5.4.4.2. Competitive Scenario
5.4.4.3. Regulatory Framework
5.4.4.4. Japan Blood Testing Market, 2018 - 2030 (USD Million)
5.4.5. Thailand
5.4.5.1. Key Country Dynamics
5.4.5.2. Competitive Scenario
5.4.5.3. Regulatory Framework
5.4.5.4. Thailand Blood Testing Market, 2018 - 2030 (USD Million)
5.4.6. South Korea
5.4.6.1. Key Country Dynamics
5.4.6.2. Competitive Scenario
5.4.6.3. Regulatory Framework
5.4.6.4. South Korea Blood Testing Market, 2018 - 2030 (USD Million)
5.4.7. Singapore
5.4.7.1. Key Country Dynamics
5.4.7.2. Competitive Scenario
5.4.7.3. Regulatory Framework
5.4.7.4. Singapore Blood Testing Market, 2018 - 2030 (USD Million)
5.5. Latin America
5.5.1. Latin America Blood Testing Market, 2018 - 2030 (USD Million)
5.5.2. Brazil
5.5.2.1. Key Country Dynamics
5.5.2.2. Competitive Scenario
5.5.2.3. Regulatory Framework
5.5.2.4. Brazil Blood Testing Market, 2018 - 2030 (USD Million)
5.5.3. Argentina
5.5.3.1. Key Country Dynamics
5.5.3.2. Competitive Scenario
5.5.3.3. Regulatory Framework
5.5.3.4. Argentina Blood Testing Market, 2018 - 2030 (USD Million)
5.6. MEA
5.6.1. MEA Blood Testing Market, 2018 - 2030 (USD Million)
5.6.2. Saudi Arabia
5.6.2.1. Key Country Dynamics
5.6.2.2. Competitive Scenario
5.6.2.3. Regulatory Framework
5.6.2.4. Saudi Arabia Blood Testing Market, 2018 - 2030 (USD Million)
5.6.3. South Africa
5.6.3.1. Key Country Dynamics
5.6.3.2. Competitive Scenario
5.6.3.3. Regulatory Framework
5.6.3.4. South Africa Blood Testing Market, 2018 - 2030 (USD Million)
5.6.4. UAE
5.6.4.1. Key Country Dynamics
5.6.4.2. Competitive Scenario
5.6.4.3. Regulatory Framework
5.6.4.4. UAE Blood Testing Market, 2018 - 2030 (USD Million)
5.6.5. Kuwait
5.6.5.1. Key Country Dynamics
5.6.5.2. Competitive Scenario
5.6.5.3. Regulatory Framework
5.6.5.4. Kuwait Blood Testing Market, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Company Categorization
6.2. Strategy Mapping
6.3. Company Market Share Analysis, 2024
6.4. Company Profiles/Listing
6.4.1. Abbott
6.4.1.1. Overview
6.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.1.3. Collection Site Benchmarking
6.4.1.4. Strategic Initiatives
6.4.2. bioMerieux
6.4.2.1. Overview
6.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.2.3. Collection Site Benchmarking
6.4.2.4. Strategic Initiatives
6.4.3. Quest Diagnostics Incorporated
6.4.3.1. Overview
6.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.3.3. Collection Site Benchmarking
6.4.3.4. Strategic Initiatives
6.4.4. Biomerica, Inc
6.4.4.1. Overview
6.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.4.3. Collection Site Benchmarking
6.4.4.4. Strategic Initiatives
6.4.5. BD
6.4.5.1. Overview
6.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.5.3. Collection Site Benchmarking
6.4.5.4. Strategic Initiatives
6.4.6. QIAGEN Siemens Healthineers AG
6.4.6.1. Overview
6.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.6.3. Collection Site Benchmarking
6.4.6.4. Strategic Initiatives
6.4.7. Danaher Corporation
6.4.7.1. Overview
6.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.7.3. Collection Site Benchmarking
6.4.7.4. Strategic Initiatives
6.4.8. Trinity Biotech Plc
6.4.8.1. Overview
6.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.8.3. Collection Site Benchmarking
6.4.8.4. Strategic Initiatives